Stockreport

Genprex, Inc. Announces Closing of $17,500,000 Common Stock Offering At-The-Market and Without Warrants

Genprex, Inc.  (GNPX) 
Last genprex, inc. earnings: 11/14 12:08 pm Check Earnings Report
PDF AUSTIN, Texas & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genprex, Inc. (“Genprex” or the “Company”) (Nasdaq: GNPX), a clinical-stage gene therapy company utilizing a uniqu [Read more]